The aim of this project was to profile the proteome of mouse-derived serum in order to identify those that showed significant quantitative different proteins among ALI mice and controls.
Plasma proteomic profiling on severe COVID - 19 patients at different stages. Revealed molecular alterations in inflammation and lipid metabolism during recovery. Identified a biomarker panel for prognosis prediction
